A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
PharmaEssentia Japan K.K.
Incyte Corporation
Protagonist Therapeutics, Inc.
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
PharmaEssentia Japan K.K.
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute
City of Hope Medical Center
Protagonist Therapeutics, Inc.
University Health Network, Toronto
Herlev Hospital
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Odense University Hospital
NS Pharma, Inc.
Hoffmann-La Roche
M.D. Anderson Cancer Center
Northwestern University
Gruppo Italiano Trapianto di Midollo Osseo
Roswell Park Cancer Institute
Novartis
Icahn School of Medicine at Mount Sinai
AOP Orphan Pharmaceuticals AG
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Novartis
Canadian Cancer Trials Group
University of California, Irvine
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Italfarmaco
Italfarmaco
Mayo Clinic
Roswell Park Cancer Institute
Icahn School of Medicine at Mount Sinai
Italfarmaco
Novartis
M.D. Anderson Cancer Center